fda drug shortage list semaglutide status january 2025 Novo's Wegovy and Ozempic removed from US list, compounders on notice FDA Announces End to Semaglutide

Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutideanalyses from a randomised, placebo-controlled study

A Retatrutide pen is a pre-filled, once-weekly injection currently being evaluated in Phase 3 clinical trials for obesity and metabolic disorders

These include limiting the intake of high-fat or greasy foods, as these can slow digestion and worsen nausea

With proper support and guidance, you can continue progressing towards your health and wellness goals

References Kalarchian M, Turk M, Elliott J, et al

Furthermore, a greater proportion of non-counseled patients (62.2%) experienced ADRs, compared to only 40.4% in the counseled groupfurther supporting the preventive impact of pharmacist-provided medication counseling (Table 3)